Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2333-2025

Novum IQ Syringe Pump, Product Code 40800BAXUS, infusion pump Recall

Novum IQ Syringe Pump, Product Code 40800BAXUS, infusion pump

FDA recall Class I

Ongoing

FDA lists this Class I recall for Novum IQ Syringe Pump, Product Code 40800BAXUS, infusion pump. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2333-2025
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Aug 4, 2025
FDA report date
Sep 10, 2025
Quantity in commerce
10,101 units
Distribution
See key details
FDA cause
Software design (manufacturing process)

What is being recalled?

Novum IQ Syringe Pump, Product Code 40800BAXUS, infusion pump

Affected model & UDI checker

Search the exact identifiers published for Z-2333-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedNovum IQ Syringe Pump, Product Code 40800BAXUS, infusion pumpCheck source notice05413765852428
FDA code information

UDI/DI 05413765852428, All Serial Numbers

View the original FDA recall notice

Why was this product recalled?

Baxter Healthcare Corporation is issuing an Urgent Medical Device Correction for the Novum IQ Large Volume Pump (LVP) and Novum IQ Syringe Pump (SP) due to software anomalies that may result in a blank Run screen (LVP and SP) and/or false motor movement system error (SP only).

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Baxter Healthcare Corporation take?

Baxter issued an "URGENT MEDICAL DEVICE CORRECTION" to its consignees on 08/04/2025 via USPS first class mail. The notice described the problem, hazard involved, and actions to be Taken by customers: 1. Users should rely on their clinical judgment. When providing patient care involving high risk medications and/or critical illness, users should consider utilizing an alternate pump, if available and appropriate for the patient's treatment. 2. If an alternate pump is not available or appropriate for patient care you may continue to use the Novum IQ LVP and Novum IQ Syringe Pump consistent with the following actions: - If a blank Run screen is displayed during an infusion on the Novum IQ LVP, the user should open the door, press the tubing into load point 3, then load point 4, to turn the light green, and close the door. If a blank Run screen is displayed during an infusion on the Novum IQ Syringe Pump, the user should unload, then reload the syringe. If these actions do not resolve the blank screen, both LVP and Syringe Pump users should power-cycle the pump, select "Yes" to the new patient prompt, and reprogram the infusion. - To prevent a false motor movement system error, do not program the Novum IQ syringe pump to infuse below the Minimum Recommended Flow Rate for a syringe size of 10 mL or greater. 3. Acknowledge receipt of this notification by following the instructions on the enclosed reply instruction sheet, even if you have no remaining inventory. 4. Please forward a copy of this communication to any departments within your institution who use the affected product. 5. Print and post Attachment A in areas frequented by potential users. For general questions regarding this communication, or if you experience quality problems, please contact your Baxter sales representative, or Baxter Global Technical Services at 800-843-7867 (select option 2, then option 2 again) Monday through Friday, between 7:00 am and 7:00 pm Eastern Time.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology